Navigation Links
Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement
Date:3/12/2008

TUCSON, Ariz., March 12 /PRNewswire-FirstCall/ -- The Providence Service Corporation (Nasdaq: PRSC) today announced that it intends to file a "shelf" registration statement for shares of its common stock on Form S-3 with the Securities and Exchange Commission, or SEC. Providence anticipates that it will file the proposed shelf registration statement immediately following the filing of its Annual Report on Form 10-K for the Year Ended December 31, 2007; however, it has no immediate plans to raise capital thereunder.

Assuming it is declared effective by the SEC, the proposed shelf registration statement would enable Providence to sell, directly to one or more investors, or to or through one or more underwriters or dealers, and/or through agents, from time to time, shares of its common stock for aggregate proceeds of up to $175 million.

Registration of shares of common stock under the proposed shelf registration statement will allow the Company to register shares in advance and provide it with the flexibility to offer the shares when market conditions are favorable or when financing needs arise. The registration of shares thereunder would not, however, mean that Providence would ever necessarily offer or sell such shares. Further, even if the proposed shelf registration statement is filed, and subsequently declared effective by the SEC, each offering, if any, that Providence determines to make pursuant to the proposed shelf registration statement would require a prospectus supplement to be filed with the terms of that offering, including, among other things, the number and price of the shares to be offered, before any such offering or sales thereunder could be made. In addition, any draw-down under the shelf registration statem
'/>"/>

SOURCE Providence Service Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance
2. Providence Service Corporation and UnitedHealth Group Affiliate, OptumHealth Behavioral Solutions, Enter Into Strategic Relationship Agreement
3. Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes
4. Providence Health & Services - Oregon Region Powers Consumer Portal With Kryptiq Connect IQ
5. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
6. LogistiCare, a Subsidiary of Providence Service Corp., Opens Phoenix Call Center to Support Expanding Commercial Client Base
7. Providence Service Corporation Signs Definitive Agreement to Acquire LogistiCare, the Nations Leading Case Management Provider Coordinating Non-Emergency Transportation Services for the Medicaid Population
8. Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes
9. Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007
10. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
11. HHS Awards $550 Million for HIV/AIDS Care, Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...e deadly traitors, good cells gone bad. They evade...f as organisms that pose no threat. , But resear...l Hill,s Eshelman School of Pharmacy are working o..., an associate professor of molecular pharmaceutic...bacterial elements in a cancer tumor in order to e...
(Date:8/20/2008)...al (MGH) investigators have found that infusions o...rotect gastrointestinal tissue from autoimmune att...n the journal Stem Cells , the team from the MGH ...enchymal stem cells (MSCs), known to control sever...ion of the gastrointestinal lining in mice with a ...
(Date:8/20/2008)...swire-USNewswire/ -- Yesterday evening,Congresswo...spital after,suffering an aneurysm while driving h...time Rep. Tubbs Jones, condition has stabilized an...day,s condition followed a full day of activity, i...al reform, scheduled for September 4, 2008,at Clev...
(Date:8/20/2008)...LEgirl.com Send Four Girls to My Beauty Camp ... Aug. 20 /PRNewswire/ -- Retin-A Micro(R) PUMP has...irl.com to send four contest,winners later this su...,California. With the new school year approaching,...e successful women by helping them build,confidenc...
Breaking Medicine News(10 mins):Health News:UNC researcher aims to 'unmask' cancer cells to trigger body's immune system 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5
...ndrome cases were 10 per 100,000 women, but droppe...tampons were // taken off the market. The number o... toxic shock syndrome statistics at 5 per 100,000 ...ociated with improper tampon use. It is an illness...
...r-sweetened soft drinks may increase a woman’s ris...researchers followed women between ages 26 and 46 ...f the participants had diabetes or any other serio...nk one or more sodas a day gained more weight and ...
...ray of hope for patients with non-small cell lung ...nvolved in research on the drug Tarceva, trying to...uding lung cancer. Tarceva is a small molecule de...wth factor receptor (HER1) pathway, also known as ...
...? Fruit and vegetables may be what you need say re...// found antioxidants in fruits and vegetables wh...ost common type of stroke caused when blood clots ...tenoids are the antioxidants found in fruits and v...
Other Medicine News:
(Date:8/19/2008)...swire/ -- Addrenex Pharmaceuticals (, http://www.a... month to,further its goal of identifying and deve...r the next 18 months., The fast-paced timeline th...,s recent successes in developing two new drugs, C...order and CloniBID for hypertension,over the past...
(Date:8/19/2008)...re-FirstCall/ -- Vical Incorporated,(Nasdaq: VICL...he Karolinska,Institute, a leading European medica...ious Disease Control (SMI), a governmental expert ...with the Biojector(R) 2000,needle-free injection s...CT) for a multivalent preventive DNA vaccine again...
(Date:8/18/2008)... /- Oramed,Pharmaceuticals,...a developer,of oral delivery systems, announced to...to Assess the Safety, Pharmacokinetics (PK) and,Ph...ons in Healthy,Subjects," has been chosen for pres...e European Association for the Study of Diabetes (...
(Date:8/17/2008)...Xinhua-- Pharmaxis,(ASX: PX...votal Phase 3,clinical trial of Bronchitol for the...ent., The first efficacy data from the trial is e...009. The trial commenced its dosing phase in,April...50 subjects in June,2008 and closed today with 325...
Breaking Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance 3543 1Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance 3543 2Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference 12824 1Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference 12824 2QED International Associates Announces Changes to the HealthShares 28TM 29 GI Gender Health Index 12822 1ARJO Inc Launches Two Innovative Products and New Campaign 12820 1
...RE)--Jun 25, 2007 - HepaLife Technologies, Inc.,(O...ed that new,data presented at an international inf...ife,s patented PBS-1 cell line outperforms,current...virus,inside its cells. The most important step to...ne against a targeted virus is the,ability to effi...
...es 75% of patients receiving highest dose,achieves...e 25, 2007 /PRNewswire-FirstCall/ -- According to,...ssions of the,American Diabetes Association (ADA) ...t liraglutide, a once- daily dose of human,GLP-1 a...eatment of,type 2 diabetes significantly improved ...
Other Medicine Technology:HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 2Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 3Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 4
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: